2007
DOI: 10.1016/j.ahj.2007.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction

Abstract: Four SNPs in platelet glycoprotein and hemostatic genes were nominally associated with acute MI rather than stable exertional angina as the initial clinical presentation of coronary artery disease. These findings are suggestive but require independent confirmation in larger studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
30
0
2

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(34 citation statements)
references
References 49 publications
(21 reference statements)
2
30
0
2
Order By: Relevance
“…Although there has been some controversy about the contribution of CD36 to atherogenesis (29), studies of several murine in vivo model systems, including high fat diet-stressed apoE Ϫ/Ϫ and LDLR Ϫ/Ϫ strains crossed into at least two CD36 Ϫ/Ϫ strains, as well as studies of CD36 Ϫ/Ϫ bone marrow chimeras and CD36 inhibitor-treated mice have shown dramatically smaller plaque lesions and/or less complex lesions with less aortic cholesterol in the absence of functional CD36 (5-8, 30, 31). Importantly, recent genome-wide association studies in humans suggest a link between CD36 polymorphisms and myocardial infarction, further supporting this hypothesis (32).…”
Section: Discussionsupporting
confidence: 55%
“…Although there has been some controversy about the contribution of CD36 to atherogenesis (29), studies of several murine in vivo model systems, including high fat diet-stressed apoE Ϫ/Ϫ and LDLR Ϫ/Ϫ strains crossed into at least two CD36 Ϫ/Ϫ strains, as well as studies of CD36 Ϫ/Ϫ bone marrow chimeras and CD36 inhibitor-treated mice have shown dramatically smaller plaque lesions and/or less complex lesions with less aortic cholesterol in the absence of functional CD36 (5-8, 30, 31). Importantly, recent genome-wide association studies in humans suggest a link between CD36 polymorphisms and myocardial infarction, further supporting this hypothesis (32).…”
Section: Discussionsupporting
confidence: 55%
“…However, the extent of the contribution of genetic risk factors to this prevalence remains unstudied. We developed a cross-sectional study of risk factors for AT, including characterization of the polymorphisms in a series of established susceptibility genes for AT, namely ACE-angiotensin converting enzyme (Rigat et al 1990;Samani et al 1996;Sabbagh et al 2007), PAI1-plasminogen activator inhibitor 1 (Onalan et al 2008), NOS3-nitric oxide synthase (Casas et al 2004), LTA-lymphotoxin a (Schreyer et al 2002;Trompet et al 2008), FGB-fibrinogen b (Renner et al 2002;Gialeraki et al 2008), ITGB3-integrin b-3 (Marian et al 1996;Ridker et al 1997;Knowles et al 2007), PON1-paraoxonase 1 (Mackness et al 1998;Salonen et al 1999;Garcés et al 2008) and APOE-apolipoprotein E (Burman et al 2009). …”
Section: Introductionmentioning
confidence: 99%
“…[21][22][23][24][25][26] SNPs in other genes from these pathways modulate CHD risk, presumably through their effects on lipids. [27][28][29][30][31] Thus, inclusion of these genes among enriched gene sets is supported by existing scientific literature.…”
Section: Discussionmentioning
confidence: 75%